General Practitioner

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform

Kim L Bennell - One of the best experts on this subject based on the ideXlab platform.

  • podiatry intervention versus usual General Practitioner care for symptomatic radiographic osteoarthritis of the first metatarsophalangeal joint a randomised clinical feasibility study
    Arthritis Care and Research, 2021
    Co-Authors: Kade L Paterson, Hylton B Menz, Rana S Hinman, Ben R Metcalf, Penny K Campbell, David J Hunter, Kim L Bennell
    Abstract:

    OBJECTIVE: To determine the feasibility of a clinical trial comparing a podiatry intervention to usual General Practitioner (GP) care for people with first metatarsophalangeal (MTP) joint osteoarthritis (OA). METHODS: A 2-arm, participant- and assessor-blinded, randomized feasibility study was conducted over 12 weeks. Participants were age >40 years and had pain and radiographic OA in the first MTP joint. Participants in the podiatry group had 3 visits and received foot orthoses, exercise, manual therapy, and advice. Participants in the GP group had 1 visit and received medication advice/prescription and the same advice as the podiatry group. Primary outcomes were measures of feasibility (recruitment, attendance, and retention rates; percentage of prescribed exercise sessions completed; orthoses wear hours/day; treatment fidelity). Secondary outcomes included self-reported pain, function, satisfaction, adherence, adverse events, and dropouts. RESULTS: A total of 236 people were screened, and 30 (13%) were included. All except 1 participant in the podiatry group attended the required clinical visits, and retention rates were 93% (podiatry group) and 80% (GP group). Participants completed 66% of the exercise sessions and wore orthoses for an average of 6.3 hours/day. Adherence to medication use was 5.3 on an 11-point numeric rating scale. Both treatment approaches improved pain and function by clinically important differences at 12 weeks. CONCLUSION: A clinical trial comparing a podiatry intervention to usual GP care for people with first MTP joint OA is feasible. Given the improvements in pain and function observed, a larger appropriately powered clinical trial is warranted to evaluate the superiority of one treatment approach over the other.

  • podiatry intervention versus usual General Practitioner care for symptomatic radiographic osteoarthritis of the first metatarsophalangeal joint a randomised clinical feasibility study
    Arthritis Care and Research, 2019
    Co-Authors: Kade L Paterson, Hylton B Menz, Rana S Hinman, Ben R Metcalf, Penny K Campbell, David J Hunter, Kim L Bennell
    Abstract:

    OBJECTIVE: To determine the feasibility of a clinical trial comparing a podiatry intervention to usual General Practitioner (GP) care for people with first metatarsophalangeal (MTP) joint osteoarthritis (OA). METHODS: A two-arm, participant- and assessor-blinded, randomised feasibility study was conducted over 12-weeks. Participants were aged over 40 years and had pain and radiographic OA in the first MTP joint. Participants in the podiatry group had 3 visits and received foot orthoses, exercise and manual therapy, and advice. Participants in the GP group had 1 visit and received medication advice/prescription, and the same advice as the podiatry group. Primary outcomes were measures of feasibility (recruitment, attendance and retention rates; percentage of prescribed exercise sessions completed; orthoses wear hours/day; treatment fidelity). Secondary outcomes included self-reported pain, function, satisfaction, adherence, adverse events and drop outs. RESULTS: Thirty people from 236 screened (13%) were included. All except one participant in the podiatry group attended the required clinical visits, and retention rates were 93% (podiatry group) and 80% (GP group). Participants completed 66% of exercise sessions and wore orthoses for an average of 6.3 hours/day. Adherence to medication use was 5.3 on 11-point NRS. Both treatments improved pain and function by clinically important differences at 12 weeks. CONCLUSION: A clinical trial comparing a podiatry intervention to usual GP care for people with first MTP joint OA is feasible. Given the improvements in pain and function observed, a larger appropriately powered clinical trial is warranted to evaluate the superiority of one treatment approach over the other.

  • no abatement of steroid injections for tennis elbow in australian General practice a 15 year observational study with random General Practitioner sampling
    PLOS ONE, 2017
    Co-Authors: Bill Vicenzino, Kim L Bennell, Helena Britt, Allan J Pollack, Michelle Hall, David J Hunter
    Abstract:

    Objective Evaluate General Practitioner (GP) management of tennis elbow (TE) in Australia. Methods Data about the management of TE by GPs from 2000 to 2015 were extracted from the Bettering the Evaluation of Care of Health program database. Patient and GP characteristics and encounter management data were classified by the International Classification of Primary Care, version 2, and reported using descriptive statistics with point estimates and 95% confidence intervals. Results TE was managed by GPs 242,000 times per year on average. Patients were mainly female (52.3%), aged between 35 and 64 years (mean: 49.3 yrs), had higher relative risks of concomitant disorders (e.g. carpal tunnel syndrome and other tendonitis) and their TE was 10 times more likely to be work related than problems managed for patients who did not have TE. Use of diagnostic tests was low, implying a clinical examination based diagnosis of TE. Management was by procedural treatments (36 per 100 TE problems), advice, education or counselling (25 per 100), and referral to other health care providers (14 per 100, mainly to physiotherapy). The rate of local injection did not change over the 15 years and was performed at similar rates as physiotherapy referral. Conclusion The high risk of comorbidities and work relatedness and no abatement in the reasonably high rate of local injections (which is contrary to the evidence from clinical trials) provides support for the development and dissemination of TE clinical guidelines for GPs.

David J Hunter - One of the best experts on this subject based on the ideXlab platform.

  • podiatry intervention versus usual General Practitioner care for symptomatic radiographic osteoarthritis of the first metatarsophalangeal joint a randomised clinical feasibility study
    Arthritis Care and Research, 2021
    Co-Authors: Kade L Paterson, Hylton B Menz, Rana S Hinman, Ben R Metcalf, Penny K Campbell, David J Hunter, Kim L Bennell
    Abstract:

    OBJECTIVE: To determine the feasibility of a clinical trial comparing a podiatry intervention to usual General Practitioner (GP) care for people with first metatarsophalangeal (MTP) joint osteoarthritis (OA). METHODS: A 2-arm, participant- and assessor-blinded, randomized feasibility study was conducted over 12 weeks. Participants were age >40 years and had pain and radiographic OA in the first MTP joint. Participants in the podiatry group had 3 visits and received foot orthoses, exercise, manual therapy, and advice. Participants in the GP group had 1 visit and received medication advice/prescription and the same advice as the podiatry group. Primary outcomes were measures of feasibility (recruitment, attendance, and retention rates; percentage of prescribed exercise sessions completed; orthoses wear hours/day; treatment fidelity). Secondary outcomes included self-reported pain, function, satisfaction, adherence, adverse events, and dropouts. RESULTS: A total of 236 people were screened, and 30 (13%) were included. All except 1 participant in the podiatry group attended the required clinical visits, and retention rates were 93% (podiatry group) and 80% (GP group). Participants completed 66% of the exercise sessions and wore orthoses for an average of 6.3 hours/day. Adherence to medication use was 5.3 on an 11-point numeric rating scale. Both treatment approaches improved pain and function by clinically important differences at 12 weeks. CONCLUSION: A clinical trial comparing a podiatry intervention to usual GP care for people with first MTP joint OA is feasible. Given the improvements in pain and function observed, a larger appropriately powered clinical trial is warranted to evaluate the superiority of one treatment approach over the other.

  • podiatry intervention versus usual General Practitioner care for symptomatic radiographic osteoarthritis of the first metatarsophalangeal joint a randomised clinical feasibility study
    Arthritis Care and Research, 2019
    Co-Authors: Kade L Paterson, Hylton B Menz, Rana S Hinman, Ben R Metcalf, Penny K Campbell, David J Hunter, Kim L Bennell
    Abstract:

    OBJECTIVE: To determine the feasibility of a clinical trial comparing a podiatry intervention to usual General Practitioner (GP) care for people with first metatarsophalangeal (MTP) joint osteoarthritis (OA). METHODS: A two-arm, participant- and assessor-blinded, randomised feasibility study was conducted over 12-weeks. Participants were aged over 40 years and had pain and radiographic OA in the first MTP joint. Participants in the podiatry group had 3 visits and received foot orthoses, exercise and manual therapy, and advice. Participants in the GP group had 1 visit and received medication advice/prescription, and the same advice as the podiatry group. Primary outcomes were measures of feasibility (recruitment, attendance and retention rates; percentage of prescribed exercise sessions completed; orthoses wear hours/day; treatment fidelity). Secondary outcomes included self-reported pain, function, satisfaction, adherence, adverse events and drop outs. RESULTS: Thirty people from 236 screened (13%) were included. All except one participant in the podiatry group attended the required clinical visits, and retention rates were 93% (podiatry group) and 80% (GP group). Participants completed 66% of exercise sessions and wore orthoses for an average of 6.3 hours/day. Adherence to medication use was 5.3 on 11-point NRS. Both treatments improved pain and function by clinically important differences at 12 weeks. CONCLUSION: A clinical trial comparing a podiatry intervention to usual GP care for people with first MTP joint OA is feasible. Given the improvements in pain and function observed, a larger appropriately powered clinical trial is warranted to evaluate the superiority of one treatment approach over the other.

  • no abatement of steroid injections for tennis elbow in australian General practice a 15 year observational study with random General Practitioner sampling
    PLOS ONE, 2017
    Co-Authors: Bill Vicenzino, Kim L Bennell, Helena Britt, Allan J Pollack, Michelle Hall, David J Hunter
    Abstract:

    Objective Evaluate General Practitioner (GP) management of tennis elbow (TE) in Australia. Methods Data about the management of TE by GPs from 2000 to 2015 were extracted from the Bettering the Evaluation of Care of Health program database. Patient and GP characteristics and encounter management data were classified by the International Classification of Primary Care, version 2, and reported using descriptive statistics with point estimates and 95% confidence intervals. Results TE was managed by GPs 242,000 times per year on average. Patients were mainly female (52.3%), aged between 35 and 64 years (mean: 49.3 yrs), had higher relative risks of concomitant disorders (e.g. carpal tunnel syndrome and other tendonitis) and their TE was 10 times more likely to be work related than problems managed for patients who did not have TE. Use of diagnostic tests was low, implying a clinical examination based diagnosis of TE. Management was by procedural treatments (36 per 100 TE problems), advice, education or counselling (25 per 100), and referral to other health care providers (14 per 100, mainly to physiotherapy). The rate of local injection did not change over the 15 years and was performed at similar rates as physiotherapy referral. Conclusion The high risk of comorbidities and work relatedness and no abatement in the reasonably high rate of local injections (which is contrary to the evidence from clinical trials) provides support for the development and dissemination of TE clinical guidelines for GPs.

Kade L Paterson - One of the best experts on this subject based on the ideXlab platform.

  • podiatry intervention versus usual General Practitioner care for symptomatic radiographic osteoarthritis of the first metatarsophalangeal joint a randomised clinical feasibility study
    Arthritis Care and Research, 2021
    Co-Authors: Kade L Paterson, Hylton B Menz, Rana S Hinman, Ben R Metcalf, Penny K Campbell, David J Hunter, Kim L Bennell
    Abstract:

    OBJECTIVE: To determine the feasibility of a clinical trial comparing a podiatry intervention to usual General Practitioner (GP) care for people with first metatarsophalangeal (MTP) joint osteoarthritis (OA). METHODS: A 2-arm, participant- and assessor-blinded, randomized feasibility study was conducted over 12 weeks. Participants were age >40 years and had pain and radiographic OA in the first MTP joint. Participants in the podiatry group had 3 visits and received foot orthoses, exercise, manual therapy, and advice. Participants in the GP group had 1 visit and received medication advice/prescription and the same advice as the podiatry group. Primary outcomes were measures of feasibility (recruitment, attendance, and retention rates; percentage of prescribed exercise sessions completed; orthoses wear hours/day; treatment fidelity). Secondary outcomes included self-reported pain, function, satisfaction, adherence, adverse events, and dropouts. RESULTS: A total of 236 people were screened, and 30 (13%) were included. All except 1 participant in the podiatry group attended the required clinical visits, and retention rates were 93% (podiatry group) and 80% (GP group). Participants completed 66% of the exercise sessions and wore orthoses for an average of 6.3 hours/day. Adherence to medication use was 5.3 on an 11-point numeric rating scale. Both treatment approaches improved pain and function by clinically important differences at 12 weeks. CONCLUSION: A clinical trial comparing a podiatry intervention to usual GP care for people with first MTP joint OA is feasible. Given the improvements in pain and function observed, a larger appropriately powered clinical trial is warranted to evaluate the superiority of one treatment approach over the other.

  • podiatry intervention versus usual General Practitioner care for symptomatic radiographic osteoarthritis of the first metatarsophalangeal joint a randomised clinical feasibility study
    Arthritis Care and Research, 2019
    Co-Authors: Kade L Paterson, Hylton B Menz, Rana S Hinman, Ben R Metcalf, Penny K Campbell, David J Hunter, Kim L Bennell
    Abstract:

    OBJECTIVE: To determine the feasibility of a clinical trial comparing a podiatry intervention to usual General Practitioner (GP) care for people with first metatarsophalangeal (MTP) joint osteoarthritis (OA). METHODS: A two-arm, participant- and assessor-blinded, randomised feasibility study was conducted over 12-weeks. Participants were aged over 40 years and had pain and radiographic OA in the first MTP joint. Participants in the podiatry group had 3 visits and received foot orthoses, exercise and manual therapy, and advice. Participants in the GP group had 1 visit and received medication advice/prescription, and the same advice as the podiatry group. Primary outcomes were measures of feasibility (recruitment, attendance and retention rates; percentage of prescribed exercise sessions completed; orthoses wear hours/day; treatment fidelity). Secondary outcomes included self-reported pain, function, satisfaction, adherence, adverse events and drop outs. RESULTS: Thirty people from 236 screened (13%) were included. All except one participant in the podiatry group attended the required clinical visits, and retention rates were 93% (podiatry group) and 80% (GP group). Participants completed 66% of exercise sessions and wore orthoses for an average of 6.3 hours/day. Adherence to medication use was 5.3 on 11-point NRS. Both treatments improved pain and function by clinically important differences at 12 weeks. CONCLUSION: A clinical trial comparing a podiatry intervention to usual GP care for people with first MTP joint OA is feasible. Given the improvements in pain and function observed, a larger appropriately powered clinical trial is warranted to evaluate the superiority of one treatment approach over the other.

Penny K Campbell - One of the best experts on this subject based on the ideXlab platform.

  • podiatry intervention versus usual General Practitioner care for symptomatic radiographic osteoarthritis of the first metatarsophalangeal joint a randomised clinical feasibility study
    Arthritis Care and Research, 2021
    Co-Authors: Kade L Paterson, Hylton B Menz, Rana S Hinman, Ben R Metcalf, Penny K Campbell, David J Hunter, Kim L Bennell
    Abstract:

    OBJECTIVE: To determine the feasibility of a clinical trial comparing a podiatry intervention to usual General Practitioner (GP) care for people with first metatarsophalangeal (MTP) joint osteoarthritis (OA). METHODS: A 2-arm, participant- and assessor-blinded, randomized feasibility study was conducted over 12 weeks. Participants were age >40 years and had pain and radiographic OA in the first MTP joint. Participants in the podiatry group had 3 visits and received foot orthoses, exercise, manual therapy, and advice. Participants in the GP group had 1 visit and received medication advice/prescription and the same advice as the podiatry group. Primary outcomes were measures of feasibility (recruitment, attendance, and retention rates; percentage of prescribed exercise sessions completed; orthoses wear hours/day; treatment fidelity). Secondary outcomes included self-reported pain, function, satisfaction, adherence, adverse events, and dropouts. RESULTS: A total of 236 people were screened, and 30 (13%) were included. All except 1 participant in the podiatry group attended the required clinical visits, and retention rates were 93% (podiatry group) and 80% (GP group). Participants completed 66% of the exercise sessions and wore orthoses for an average of 6.3 hours/day. Adherence to medication use was 5.3 on an 11-point numeric rating scale. Both treatment approaches improved pain and function by clinically important differences at 12 weeks. CONCLUSION: A clinical trial comparing a podiatry intervention to usual GP care for people with first MTP joint OA is feasible. Given the improvements in pain and function observed, a larger appropriately powered clinical trial is warranted to evaluate the superiority of one treatment approach over the other.

  • podiatry intervention versus usual General Practitioner care for symptomatic radiographic osteoarthritis of the first metatarsophalangeal joint a randomised clinical feasibility study
    Arthritis Care and Research, 2019
    Co-Authors: Kade L Paterson, Hylton B Menz, Rana S Hinman, Ben R Metcalf, Penny K Campbell, David J Hunter, Kim L Bennell
    Abstract:

    OBJECTIVE: To determine the feasibility of a clinical trial comparing a podiatry intervention to usual General Practitioner (GP) care for people with first metatarsophalangeal (MTP) joint osteoarthritis (OA). METHODS: A two-arm, participant- and assessor-blinded, randomised feasibility study was conducted over 12-weeks. Participants were aged over 40 years and had pain and radiographic OA in the first MTP joint. Participants in the podiatry group had 3 visits and received foot orthoses, exercise and manual therapy, and advice. Participants in the GP group had 1 visit and received medication advice/prescription, and the same advice as the podiatry group. Primary outcomes were measures of feasibility (recruitment, attendance and retention rates; percentage of prescribed exercise sessions completed; orthoses wear hours/day; treatment fidelity). Secondary outcomes included self-reported pain, function, satisfaction, adherence, adverse events and drop outs. RESULTS: Thirty people from 236 screened (13%) were included. All except one participant in the podiatry group attended the required clinical visits, and retention rates were 93% (podiatry group) and 80% (GP group). Participants completed 66% of exercise sessions and wore orthoses for an average of 6.3 hours/day. Adherence to medication use was 5.3 on 11-point NRS. Both treatments improved pain and function by clinically important differences at 12 weeks. CONCLUSION: A clinical trial comparing a podiatry intervention to usual GP care for people with first MTP joint OA is feasible. Given the improvements in pain and function observed, a larger appropriately powered clinical trial is warranted to evaluate the superiority of one treatment approach over the other.

Ben R Metcalf - One of the best experts on this subject based on the ideXlab platform.

  • podiatry intervention versus usual General Practitioner care for symptomatic radiographic osteoarthritis of the first metatarsophalangeal joint a randomised clinical feasibility study
    Arthritis Care and Research, 2021
    Co-Authors: Kade L Paterson, Hylton B Menz, Rana S Hinman, Ben R Metcalf, Penny K Campbell, David J Hunter, Kim L Bennell
    Abstract:

    OBJECTIVE: To determine the feasibility of a clinical trial comparing a podiatry intervention to usual General Practitioner (GP) care for people with first metatarsophalangeal (MTP) joint osteoarthritis (OA). METHODS: A 2-arm, participant- and assessor-blinded, randomized feasibility study was conducted over 12 weeks. Participants were age >40 years and had pain and radiographic OA in the first MTP joint. Participants in the podiatry group had 3 visits and received foot orthoses, exercise, manual therapy, and advice. Participants in the GP group had 1 visit and received medication advice/prescription and the same advice as the podiatry group. Primary outcomes were measures of feasibility (recruitment, attendance, and retention rates; percentage of prescribed exercise sessions completed; orthoses wear hours/day; treatment fidelity). Secondary outcomes included self-reported pain, function, satisfaction, adherence, adverse events, and dropouts. RESULTS: A total of 236 people were screened, and 30 (13%) were included. All except 1 participant in the podiatry group attended the required clinical visits, and retention rates were 93% (podiatry group) and 80% (GP group). Participants completed 66% of the exercise sessions and wore orthoses for an average of 6.3 hours/day. Adherence to medication use was 5.3 on an 11-point numeric rating scale. Both treatment approaches improved pain and function by clinically important differences at 12 weeks. CONCLUSION: A clinical trial comparing a podiatry intervention to usual GP care for people with first MTP joint OA is feasible. Given the improvements in pain and function observed, a larger appropriately powered clinical trial is warranted to evaluate the superiority of one treatment approach over the other.

  • podiatry intervention versus usual General Practitioner care for symptomatic radiographic osteoarthritis of the first metatarsophalangeal joint a randomised clinical feasibility study
    Arthritis Care and Research, 2019
    Co-Authors: Kade L Paterson, Hylton B Menz, Rana S Hinman, Ben R Metcalf, Penny K Campbell, David J Hunter, Kim L Bennell
    Abstract:

    OBJECTIVE: To determine the feasibility of a clinical trial comparing a podiatry intervention to usual General Practitioner (GP) care for people with first metatarsophalangeal (MTP) joint osteoarthritis (OA). METHODS: A two-arm, participant- and assessor-blinded, randomised feasibility study was conducted over 12-weeks. Participants were aged over 40 years and had pain and radiographic OA in the first MTP joint. Participants in the podiatry group had 3 visits and received foot orthoses, exercise and manual therapy, and advice. Participants in the GP group had 1 visit and received medication advice/prescription, and the same advice as the podiatry group. Primary outcomes were measures of feasibility (recruitment, attendance and retention rates; percentage of prescribed exercise sessions completed; orthoses wear hours/day; treatment fidelity). Secondary outcomes included self-reported pain, function, satisfaction, adherence, adverse events and drop outs. RESULTS: Thirty people from 236 screened (13%) were included. All except one participant in the podiatry group attended the required clinical visits, and retention rates were 93% (podiatry group) and 80% (GP group). Participants completed 66% of exercise sessions and wore orthoses for an average of 6.3 hours/day. Adherence to medication use was 5.3 on 11-point NRS. Both treatments improved pain and function by clinically important differences at 12 weeks. CONCLUSION: A clinical trial comparing a podiatry intervention to usual GP care for people with first MTP joint OA is feasible. Given the improvements in pain and function observed, a larger appropriately powered clinical trial is warranted to evaluate the superiority of one treatment approach over the other.